rs16967611

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_012448.4(STAT5B):​c.-10-17412T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.371 in 152,046 control chromosomes in the GnomAD database, including 12,080 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 12080 hom., cov: 32)

Consequence

STAT5B
NM_012448.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.890

Publications

15 publications found
Variant links:
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
  • growth hormone insensitivity syndrome with immune dysregulation
    Inheritance: SD Classification: DEFINITIVE Submitted by: Illumina
  • growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • growth hormone insensitivity with immune dysregulation 1, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • growth hormone insensitivity syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012448.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
NM_012448.4
MANE Select
c.-10-17412T>C
intron
N/ANP_036580.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
ENST00000293328.8
TSL:1 MANE Select
c.-10-17412T>C
intron
N/AENSP00000293328.3
STAT5B
ENST00000468312.1
TSL:1
n.160-17412T>C
intron
N/A
STAT5B
ENST00000951702.1
c.-10-17412T>C
intron
N/AENSP00000621761.1

Frequencies

GnomAD3 genomes
AF:
0.371
AC:
56379
AN:
151928
Hom.:
12042
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.591
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.216
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.355
Gnomad SAS
AF:
0.425
Gnomad FIN
AF:
0.237
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.294
Gnomad OTH
AF:
0.370
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.371
AC:
56470
AN:
152046
Hom.:
12080
Cov.:
32
AF XY:
0.368
AC XY:
27331
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.592
AC:
24517
AN:
41432
American (AMR)
AF:
0.216
AC:
3299
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1169
AN:
3472
East Asian (EAS)
AF:
0.357
AC:
1847
AN:
5178
South Asian (SAS)
AF:
0.424
AC:
2047
AN:
4828
European-Finnish (FIN)
AF:
0.237
AC:
2507
AN:
10576
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.294
AC:
20015
AN:
67978
Other (OTH)
AF:
0.369
AC:
781
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1661
3321
4982
6642
8303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.341
Hom.:
1663
Bravo
AF:
0.376
Asia WGS
AF:
0.447
AC:
1551
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.48
DANN
Benign
0.80
PhyloP100
-0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16967611; hg19: chr17-40401567; API